Member Info for Prion25

Sunak speaking in HC few minutes ago something like 60 million for hydrogen development and fuels cell technology

Why the big drop in the last 3 months reaching 5 year low ?

Https://sifted.eu/articles/solar-energy-breakthrough-solid-hydrogen

Reverse hydrogen fuel cell technology Is this Ceres ‘s SOFC patented technology?

Pony4sal

Thanks for the clarification for my oversight seems like a massive drop from Berenberg 's rating over £11 in July But I will continue to hold my shares I am not going to let any Broker ratings scare me into selling I rate the company very highly

Goldman Sachs cuts Ceres Power price target to 510 (540) pence - 'buy'

Goldman Sachs cuts Ceres Power price target to 320 (510) pence - 'buy'

Depending which share you "news" you click on ITM or Ceres you get a disparity in the brokers target price which is correct?

Apologies for the turmoil on my phone this morning

Here is the crux paragraph from the link ref myelosuppression. The poster can be found on the Avacta website

" AVA6000 utilises Avacta's pre|CISION™ platform to improve the safety and therapeutic index of doxorubicin. AVA6000 has been designed to limit cell penetration of the drug, and therefore its cell killing effect, until it is specifically activated FAP, which is in high concentration in many solid tumours compared with healthy tissues. The resulting reduced exposure of healthy tissues to active doxorubicin has the potential to significantly increase its therapeutic index by reducing the incidence of adverse effects, including cardiotoxicity and myelosuppression. A first-in-human Phase I clinical trial (ALS-6000-101) has been initiated in the UK in a broad spectrum of high FAP expressing tumours."

https://*********************/newsfeed/article/avacta-group-plc-ava6000-data-poster-presentation-at-aacr-1379501

https://*********************/newsfeed/article/avacta-group-plc-ava6000-data-poster-presentation-at-aacr-1379501

https://*********************/newsfeed/article/avacta-group-plc-ava6000-data-poster-presentation-at-aacr-1379501

fda approved ava6000 on increased therapeutic index toxicity effects of cardio /myelosuppression reduced

The CEO should know what’s going on Why would he buy shares What would be his motive to through away 100 or more grand The way the SP is behaving is down to other external factors which MMs exploit nervous share holders

Https://www.gov.uk/government/publications/uk-hydrogen-strategy/uk-hydrogen-strategy-accessible-html-version

A poster recently said the UK was no longer interested in hydrogen economy and hence the reason for SP drop The above link suggest otherwise and ITM and Ceres are mentioned .I am a new investor bought over £4 and now averaging down This is the future ,the green hydrogen revolution ,to solve the energy crisis caused by Ukraine war and possibly another Arab Israeli war and of course climate change

I am not sure if the UK is turning away from hydrogen but I am sure that Germany and EU are quickly developing their hydrogen economies when King Charles spoke in the Germany Parliament he alluded to this transformation to combat climate change.Ceres will be instrumental in the transformation

What are the implications of the Belt and Road summit and the geopolitical and economic that may affect Ceres , anybody ??

Just as ITM have thrown their at in the ring you would think Ceres would be on the US bandwagon .The White House statement is very encouraging for the future of Clean Energy. but which companies will benefit ?

# Lancet news

What’s the game here why haven’t they released a RNS on Lancet new and significant COPD news ?

Looking at the charts this indicates it is almost at a 5 year low . Is this the bottom and why is lingering there ? I would buy more if cash comes available just hope it lingers a little longer.

@B2HS2L

Thanks for your reply

ATB

P25

Thanks Buena Vista

I had just done that before you posted and seen numerous names including Avacta all referring to this to this single scaffolding affirmer. Then there was a virus alert on my laptop so I quickly aborted the search GLA

From the Leeds University Publication

"Conflicts of interest. MJM and DCT are named inventors of the Affimer technology and this is

filed under U.S. patent number #10,844,370 assigned to the University of Leeds on ‘Scaffold

proteins derived from plant cystatins’."

who are the named inventors ?